High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$13.1M
$13,105,233
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2026-02-17
$8,103,281Whalex2
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2026-02-17 | $8,103,281Whalex2 | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
2026-02-17
$13,105,233MEGAx3
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
|
2026-02-17 | $13,105,233MEGAx3 | S | Form 4 |